Carbidopa Levodopa

FDA Drug Profile — Dhivy

Carbidopa Levodopa is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Dhivy. Available dosage form: tablet.

Drug details

Generic Name
Carbidopa Levodopa
Brand Names
Dhivy
Application Number
NDA214869
Sponsor
Avion Pharmaceuticals, LLC
NDC Codes
2
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
CARBIDOPA HYDRATE, LEVODOPA

Indications and Usage

1 INDICATIONS AND USAGE DHIVY is indicated for the treatment of Parkinson’s disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. DHIVY is a combination of carbidopa (an aromatic amino acid decarboxylation inhibitor) and levodopa (an aromatic amino acid) indicated for the treatment of Parkinson’s disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.